Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular characterization of the 17D-204 yellow fever vaccine.

Vaccine - 5 Oct 2015

Salmona Maud, Gazaignes Sandrine, Mercier-Delarue Severine, Garnier Fabienne, Korimbocus Jehanara, Colin de Verdière Nathalie, LeGoff Jerome, Roques Pierre, Simon François

Abstract excerpt

INTRODUCTION: The worldwide use of yellow fever (YF) live attenuated vaccines came recently under close scrutiny as rare but serious adverse events have been reported. The population identified at major risk for these safety issues were extreme ages and immunocompromised subjects. Study NCT01426243 conducted by the French National Agency for AIDS research is an ongoing interventional study to evaluate the safety...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cluster Analysis
Share to Coinfection

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to France

Share to HIV Infections

Share to Vaccines, Attenuated

Share to Viral Proteins

Share to Yellow Fever

Share to Yellow fever virus

Source

Identifiers

PMID: 26314624
DOI: 10.1016/j.vaccine.2015.08.055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular characterization of the 17D-204 yellow fever vaccine.PMID 26314624Read ↗

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal modelsSemantic proximity Read ↗

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differencesSemantic proximity Read ↗

Sanger-based sequencing technology for yellow fever vaccine genetic quality control.Semantic proximity Read ↗

The phylogeny of yellow fever virus 17D vaccines.Semantic proximity Read ↗

Phenotypic and genetic characterization of a next generation live-attenuated yellow fever vaccine candidate.Semantic proximity Read ↗

Molecular analysis of yellow fever virus 17DD vaccine strain.Semantic proximity Read ↗

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213Semantic proximity Read ↗

Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations.Semantic proximity Read ↗

Mutation in a 17D-204 Vaccine Substrain-Specific Envelope Protein Epitope Alters the Pathogenesis of Yellow Fever Virus in MiceSemantic proximity Read ↗

The yellow fever 17D virus as a platform for new live attenuated vaccinesSemantic proximity Read ↗

The Yellow Fever Vaccine Journey: Milestones and Future DirectionsSemantic proximity Read ↗

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.